INS and metabolic dysfunction-associated steatohepatitis: For the patient with NASH, the associated weight gain with insulin creates a management conundrum; this is especially true for patients with cirrhosis who are given tight glycaemic control and weight loss targets to qualify for listing for transplant at many centres.